Tag: Iovance Biotherapeutics innovation

Home / Iovance Biotherapeutics innovation

Categories

Iovance’s Amtagvi is approved by USFDA as first T-cell therapy for a solid tumor

Iovance Biotherapeutics' first-of-its-kind immunotherapy was approved by the FDA. This means that T-cell therapy, which has changed the way some types of blood cancer are treated, can now be used dir...
iovance-biotherapeutics-innovation

Scan the code